Three stocks that have not only been around for a century but have also been paying dividends for that long are Coca-Cola ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

The Danish drugmaker and rival Eli Lilly have together sued dozens of medical spas, weight-loss clinics, compounding ...

“Supply chain issues and the dominance of a few pharmaceutical companies keep prices of some products high and unaffordable ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ...

Hartford HealthCare is partnering with the American School for the Deaf to reduce communication barriers for deaf and hard-of ...

In a decision on Wednesday, U.S. District Judge Mary Rowland said the Illinois, California and New York consumers leading the lawsuit plausibly alleged that Kraft Mac & Cheese contained a synthetic ...

Positive long-term extension data highlighting the differentiated profile of deucrictibant for the prevention and treatment of HAE attacks presented at recent medical congresses Intend to engage in ...